deutsch
Congresses
We will present our company and our products at the following congresses:
Birmingham ICC, UK
Harrogate, UK
Sutton Coldfield, UK
Liverpool, UK
Southampton, UK
Glasgow, UK
Liverpool, UK
Vancouver, Canada
Biomedical Science Congress 2011
Sep 26 – Sep 28, 2011Birmingham ICC, UK
Focus 2011
May 24 – May 26, 2011Harrogate, UK
Pancreatic Society of Great Britain and Ireland Annual Meeting 2010
Dec 2 – Dec 3, 2010Sutton Coldfield, UK
NCRI Cancer Conference 2010
Nov 7 – Nov 9, 2010Liverpool, UK
Pancreatic Diseases Meeting 2010
Sep 30 – Oct 1, 2010Southampton, UK
Focus 2010
May 11 – May 13, 2010Glasgow, UK
BSG Annual Meeting 2010
Mar 23 – Mar 25, 2010Liverpool, UK
Keystone Symposium
Mar 12 - Mar 17, 2010Vancouver, Canada
A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
more...